Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2018

Nov 1, 2018

284_dirs_2018-11-01_1e72297b-b99c-42c1-bfc8-e08e5a88ce2c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2018-10-30

Reporting Person: MIZELL STEVEN (EVP, Human Resources)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-10-30 Restricted Stock Unit $ A 13723.0000 Acquired 2021-10-30 Common Stock (13723.0000) Direct
2018-10-30 Stock Option (right to buy) $72.8700 A 51252.0000 Acquired 2028-10-29 Common Stock (51252.0000) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F2: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.

F3: The option vests and becomes exercisable in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.